8
Participants
Start Date
January 17, 2022
Primary Completion Date
June 24, 2022
Study Completion Date
June 24, 2022
Lemzoparlimab
Intravenous (IV) infusion
Dexamethasone
Oral tablet or IV infusion/injection
Carfilzomib
IV infusion
Pomalidomide
Oral capsule
Daratumumab
Subcutaneous (SC) injection
Alfred Health /ID# 229347, Melbourne
The Queen Elizabeth Hospital /ID# 229345, Woodville South
Hospital Universitario Reina Sofia /ID# 229388, Córdoba
Hospital Clínico Universitario de Santiago-CHUS /ID# 229356, Santiago de Compostela
Asklepios Klinik Altona /ID# 229143, Hamburg
University of Virginia /ID# 229396, Charlottesville
Duke University Hospital /ID# 229564, Durham
Hospital Universitario 12 de Octubre /ID# 229355, Madrid
Hospital Unversitario Marques de Valdecilla /ID# 229354, Santander
Norton Cancer Institute - St Matthews /ID# 229319, Louisville
CHU de Nantes, Hotel Dieu -HME /ID# 228559, Nantes
University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 229309, Ann Arbor
Henry Ford Health System /ID# 230341, Detroit
HCL - Hôpital Lyon Sud /ID# 229834, Pierre-Bénite
Tulane Cancer Center Clinic /ID# 229832, New Orleans
CHU Poitiers - La milétrie /ID# 229833, Poitiers
Hadassah Medical Center-Hebrew University /ID# 229477, Jerusalem
Hopital Henri Mondor /ID# 228562, Créteil
Rambam Health Care Campus /ID# 229485, Haifa
Meir Medical Center /ID# 229480, Kfar Saba
Rabin Medical Center /ID# 229488, Petah Tikva
The Chaim Sheba Medical Center /ID# 229483, Ramat Gan
Tel Aviv Sourasky Medical Center /ID# 229478, Tel Aviv
Sylvester Comprehensive Cancer Center /ID# 228817, Miami
Moffitt Cancer Center /ID# 229939, Tampa
Rutgers Cancer Institute of New Jersey /ID# 230174, New Brunswick
Columbia University Medical Center /ID# 229971, New York
Wake Forest Baptist Health /ID# 229996, Winston-Salem
Perelman Center for Advanced Medicine - /ID# 228693, Philadelphia
University Hospital Kyoto Prefectural University of Medicine /ID# 241833, Kyoto
Hospital Parc de Salut del Mar /ID# 229371, Barcelona
Hospital Santa Creu i Sant Pau /ID# 229369, Barcelona
Lead Sponsor
AbbVie
INDUSTRY